Ετικέτες

Τετάρτη 31 Μαΐου 2017

The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment

Abstract

Background

Testosterone treatment in obese dieting men augments the diet-associated loss of fat mass, but protects against loss of lean mass. We assessed whether body composition changes are maintained following withdrawal of testosterone treatment.

Methods

We conducted a pre-specified double-blind randomised placebo-controlled observational follow-up study of a randomized controlled trial (RCT). Participants were men with baseline obesity (body mass index ≥ 30kg/m2) and a repeated total testosterone level ≤ 12nmol/L, previously enrolled in a 56-week testosterone-treatment trial combined with a weight loss program. Main outcome measures were mean adjusted differences (MAD) (95% confidence interval), in body composition between testosterone and placebo-treated men at the end of the observation period.

Results

Of the 100 randomised men, 82 completed the RCT, and 64 the subsequent observational study. Median [IQR] observation time after completion of the RCT was 82 weeks [74; 90] in men previously receiving testosterone (cases) and 81 weeks [67; 91] in men previously receiving placebo (controls), p=0.51. At the end of the RCT, while losing similar amounts of weight, cases had, compared to controls, lost more fat mass, MAD -2.9kg (-5.7, -0.2), p=0.04, but had lost less lean mass MAD 3.4kg (1.3, 5.5), p=0.002. At end of the observation period, the former between group differences in fat mass, MAD -0.8kg, (-3.6, 2.0), p=1.0, in lean mass, MAD -1.3kg (-3.0, 0.5), p=0.39, and in appendicular lean mass, MAD -0.1kg/m2 (-0.3, 0.1), p=0.45, were no longer apparent. During observation, cases lost more lean mass, MAD -3.7kg (-5.5, -1.9), p=0.0005 and appendicular lean mass, MAD -0.5kg/m2 (-0.8, -0.3), p<0.0001 compared to controls.

Conclusions

The favourable effects of testosterone on body composition in men subjected to a concomitant weight loss program were not maintained at 82 weeks after testosterone treatment cessation.

This article is protected by copyright. All rights reserved.



http://ift.tt/2qA7K1G

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου